HIROTSU BIO SCIENCE INC. recently increased its capital through the allocation of new shares to third parties. To deliver N-NOSE, a new method that can speed up the detection and treatment of cancer, to many others, we will work to build awareness while also strengthening our test supply system.
On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queens . . .2022.06.08
We have formed a business alliance with Sojitz Corporation.→PRESS RELEASE2022.03.11
We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare pr . . .2022.03.11